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Associate Professor of Pharmacy Practice and Administration, Northeastern University School of Pharmacy 
 
It is commonly believed that if you give individuals financial incentives for a particular action they will be more likely to engage in 
that action.  This concept of reward-behavior pairing stems from classic experimental research led by the Russian physiologist Ivan 
Pavlov and American Psychologist B.F. Skinner.  Value expectancy theorists of the 1930’s and 40’s also supported similar concepts in 
the notion that individuals are more likely to engage in a particular behavior if they value the outcome of the behavior and believe it 
is likely that the behavior will result in the valued outcome.  Predicated on these well accepted theories, it is reasonable to 
anticipate that financial incentives will lead to improved medication adherence behavior.   
 
Conley and Hughes, however, found this is not necessarily always true.  They found no significant differences in medication 
adherence between enrollment and 6 months post enrollment of a patient assistance program or receiving prescription benefits 
through a state’s Medicaid program.  Students of psychosocial behavior ask themselves why are such findings discrepant with theory 
and prior literature reviewed by the authors.  Part of the explanation could be attributed to small sample size (lack of power), study 
measures, or other methodological issues.  
  
However, patients may have been non-adherent due to other reasons.  Barriers/perceptions toward continued medication use are 
dynamic and change over time due to various outcomes experienced and the alternatives available.
1
 For example, the authors 
reported that those in the Patient Assistance Program experienced a decrease in motivation over time.  The lack of motivation may 
have been due to side effects, lack of perceived need for the medication, the lack of a pharmacist-patient relationship, decreased 
self-efficacy in taking the medication, etc.  In addition, the negative motivation may be due to changes in the perceived value of the 
medication given new alternatives that have come available and for which the patient desires change.  The lack of interventions 
targeting these or other reasons may have contributed to the lack of change in adherence between baseline and 6 months post 
enrollment. 
 
Clearly, to have an impact on medication adherence, we need to assess the reason for the non-adherence and creatively target it.  
We also need to appreciate that perceptions of continued medication use is a dynamic process that can change due to ongoing 
patient re-evaluation of outcomes and alternatives.  “One size fits all and static” approaches are not likely viable and sustainable in 
improving medication adherence.  The medication adherence research community has and continues to learn that, at the individual 
level, we need to tailor interventions across time to an individual’s changing concerns and, at the population level, we need to 
segment the population to those most likely to have specific adherence barriers, target these barriers, and evaluate the 
effectiveness of such populations-based interventions.    
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Editor’s Note:  INNOVATIONS in pharmacy welcomes papers that generate new ideas and discussion about those ideas.  The pilot 
study by Conley and Hughes provides this.  We asked Dr. Rickles to write this commentary in order to add to this important 
discussion. 
